FIELD: medicine; pharmaceuticals.
SUBSTANCE: for this purpose, a composition is used which contains as an active ingredient a mixture of amino acids consisting of glycine, L-proline, L-alanine, L-valine, L-leucine and L-lysine hydrochloride in the declared weight ratios. Invention stimulates the synthesis of both collagen and elastin.
EFFECT: invention refers to pharmaceutics and can be used for recovering fibroelastin in dermal connective tissues.
11 cl, 2 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR PROMOTING ELASTIN AND COLLAGEN BIOSYNTHESIS IN CONNECTIVE TISSUE | 2020 |
|
RU2778368C2 |
| INJECTED MEDICAL COMPOSITION | 2021 |
|
RU2788726C1 |
| IN VIVO SYNTHESIS OF ELASTIC FIBER | 2012 |
|
RU2602861C2 |
| PEPTIDES FOR SKIN REJUVENATION AND METHODS OF THEIR USAGE | 2014 |
|
RU2666533C2 |
| SYSTEM OF TRANSDERMAL TRANSFER ENHANCERS AND COSMETIC COMPOSITIONS BASED THEREON | 2020 |
|
RU2736504C1 |
| SYNTHESIS OF ELASTIC FIBER IN VIVO | 2012 |
|
RU2727510C2 |
| ANTI-AGING AND WOUND-HEALING COMPOSITIONS | 2002 |
|
RU2318873C2 |
| BIFUNCTIONAL PEPTIDE | 2013 |
|
RU2639573C2 |
| COSMETIC OR DERMATOLOGICAL COMPOSITIONS COMBINING RETINALDEHYDE AND GLYCYLGLYCINE OLEAMIDE AND COSMETIC OR DERMATOLOGICAL USES THEREOF | 2014 |
|
RU2660359C2 |
| COMPOSITION FOR SKIN PROTECTION FROM EXPOSURE TO HARMFUL SUBSTANCES, LIGHT AND STRESS | 2021 |
|
RU2792212C1 |
